Bladder Cancer

[18F]Fluoro-Deoxy-Glucose Positron Emission Tomography to Evaluate Lymph Node Involvement in Patients with Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Pembrolizumab - Beyond the Abstract January 22, 2021

Can Anesthetics Affect Bladder Cancer Recurrence? Total Intravenous Versus Volatile Anesthesia in Patients Undergoing Robot-Assisted Radical Cystectomy: A Single Institution Retrospective Analysis - Beyond the Abstract January 22, 2021

Can Immune Markers Help Identify Fast Relapse in Patients With Muscle Invasive Bladder Cancer? - Beyond the Abstract January 21, 2021

Intracorporeal Versus Extracorporeal Urinary Diversion Following Robot-Assisted Radical Cystectomy: A Meta-Analysis, Cumulative Analysis, and Systematic Review - Beyond the Abstract January 15, 2021

Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program - Beyond the Abstract January 14, 2021

Identification of a Synthetic Lethal Relationship Between Nucleotide Excision Repair (NER) Deficiency and Irofulven Sensitivity in Urothelial Cancer - Beyond the Abstract January 12, 2021

Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-Analysis - Beyond the Abstract January 11, 2021

Association Between Metabolic Syndrome and Recurrence of Nonmuscle-Invasive Bladder Cancer in Older Adults - Beyond the Abstract January 4, 2021

Current Treatments for BCG Failure in Non-Muscle Invasive Bladder Cancer - Beyond the Abstract December 10, 2020

Comparison of Renal Function After Open Radical Cystectomy, Extracorporeal Robot Assisted Radical Cystectomy, and Intracorporeal Robot Assisted Radical Cystectomy - Beyond the Abstract December 7, 2020

The Urinary Microbiome: A New Potential Target in Bladder Cancer Precision Medicine? - Beyond the Abstract December 1, 2020

Can We Perform Frozen Section Instead of Repeat Transurethral Resection in Bladder Cancer? - Beyond the Abstract November 12, 2020

Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences - Beyond the Abstract November 10, 2020

Inguinal Lymph Node Metastasis of Bladder Carcinoma After Radical Cystectomy: A Case Report and Review of Literature - Beyond the Abstract November 6, 2020

New Immunotherapies for High-Risk Non-Muscle Invasive Bladder Cancer: Current State and Future Perspectives - Beyond the Abstract November 3, 2020

Race Modifies Survival Benefit of Guideline-Based Treatment: Implications for Reducing Disparities in Muscle Invasive Bladder Cancer - Beyond the Abstract October 28, 2020

Reassessment of P53 Immunohistochemistry Thresholds in Invasive High Grade Bladder Cancer Shows a Better Correlation with TP53 and FGFR3 Mutations - Beyond the Abstract October 27, 2020

Urinary Biomarkers in Bladder Cancer: A Review of the Current Landscape and Future Directions - Beyond the Abstract October 21, 2020

Comparison of Major Complications at 30 and 90 days Following Radical Cystectomy - Beyond the Abstract October 20, 2020

Nomogram Predicting Bladder Cancer-Specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer: Results of an International Consortium - Beyond the Abstract October 19, 2020

Page 1 of 16